The documentary, called The Bleeding Edge, explores the personal stories of everyday people, as well as medical professionals, who’ve suffered severe complications from medical devices. The film also examines the inner workings of the $400 billion medical device industry and theFDA’s approval process, questioning whether innovative therapies should immediately be accepted as superior to more research-backed treatments.
While much of the film revolves around the controversial birth control device Essure, which Bayer will remove from the U.S. market by the end of the year, the documentary also highlights complications from other medical devices, such as surgical robots and cobalt hip joints, according to The Village Voice.
The Bleeding Edge premieres July 27 on Netflix.
Editor’s Note: This article was updated July 30 at 12:38 p.m. to reflect that Bayer will remove Essure from the market by the end of the year.
More articles on supply chain:
Reuters: Amazon in talks to buy Indian pharmacy chain
Bayer pulls birth control implant Essure from US market: 5 things to know
Endometriosis, malaria & leukemia treatments: 5 FDA approvals this week
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
